Skip to content

Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET

Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET.A Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008240
Enrollment
160
Registered
2013-12-11
Start date
2011-08-31
Completion date
2014-05-31
Last updated
2015-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Infertility, Hydrosalpinx, IVF-ET, Salpingectomy

Brief summary

The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with ultrasound visible hydrosalpinges undergoing IVF-ET.

Detailed description

The adverse impact of hydrosalpinx on in vitro fertilisation embryo transfer (IVF-ET) outcomes has been confirmed by several retrospective and prospective studies . Cochrane review of prospective randomised trials of laparoscopic salpingectomy confirmed the beneficial effect of laparoscopic salpingectomy on IVF-ET outcomes in patients with hydrosalpinges. Surgery is not usually safe especially in patients with extensive adhesions, morbid obesity or previous multiple laparotomies. Furthermore, many infertile couples refuse to undergo bilateral salpingectomy or proximal tubal occlusion because these procedures remove any hope of spontaneous pregnancy. Other less invasive options for patients with hydrosalpinges as ultrasound-guided aspiration of hydrosalpingeal fluid, antibiotics (alone or combined with aspiration) and hysteroscopic occlusion of fallopian tube were studied in order to find an alternative to salpingectomy . Although these methods are simple and getting popular, current data are inadequate to recommend these treatment options instead of salpingectomy because most of the supporting evidences for these methods come from small retrospective studies. A recent randomized controlled trial revealed that the aspiration of hydrosalpingeal fluid at the time of oocyte retrieval was associated with improved implantation rate and pregnancy rates. The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with ultrasound visible hydrosalpinges undergoing IVF-ET

Interventions

PROCEDURENeedle aspiration of hydrosalpinx

Under deep sedation, the retrieval of oocytes is done and then an aspiration needle is inserted into the hydrosalpinx under ultrasonographic guidance and suction is applied to aspirate the hydrosalpingeal fluid completely . If there are bilateral hydrosalpinges, the process is repeated on the opposite side.

PROCEDURESalpingectomy

laparoscopic surgical removal of affected tube is done with bipolar electrocoagulation for hemostasis. The mesosalpinx is coagulated as close a possible to the fallopian tube to avoid any compromise in the ovarian blood supply . In cases with marked adhesion, proximal ligation and a distal fenestration is done .

Sponsors

Aljazeera Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 37 Years
Healthy volunteers
No

Inclusion criteria

* Patients with unilateral or bilateral hydrosalpinges visible by ultrasound * Age between 18 - 37 years * Period of infertility \> 1 year * Body mass index between 19-29 * Normal basal luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin concentrations. * Normal recent semen analysis (according to World Health Organization criteria).

Exclusion criteria

* Uterine fibroid requiring surgical removal. * Endometriosis. * Male factor of infertility requiring ICSI, Previous IVF cycles. * History of recurrent miscarriage. * Endocrinologic disorders. * Presence of systemic disease contraindicating pregnancy.

Design outcomes

Primary

MeasureTime frame
The Number of Participants Who Achieved Clinical Pregnancy in a Transfer Cycle5 weeks after embryo transfer

Secondary

MeasureTime frame
The Number of Participants Who Achieved Ongoing Pregnancy in a Transfer Cycle .18 weeks after embryo transfer

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026